CLINICAL_TRIALS
trial_result
· 2009-02-02
Clinical Trial Update: Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA) [Phase 3]
Summary
A Phase 3 double-blind comparative trial evaluating MRA for rheumatoid arthritis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chugai Pharmaceutical | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED